Podcasts to help you keep up with the latest trends

We delve into the rapidly evolving world of psychedelic investments and the key differences between investing in the psychedelic and cannabis sectors.

We discuss the far-reaching implications of the Inflation Reduction Act (IRA) on the US healthcare system, with a particular focus on drug pricing and price negotiations between the US federal government and pharmaceutical companies, as well as the impact on health plans.

In this episode of the Signals podcast, we speak to Matt Melander, a successful entrepreneur in the burgeoning cannabis industry. We delve into the challenges and opportunities of creating and distributing cannabis-infused beverages and edibles, highlighting Matt's journey in developing the popular LEVIA beverage line.

In this episode we spoke with John Zolidis, President at Quo Vadis Capital. John has over 25 years of Wall Street experience analyzing unit-based businesses, such as restaurants and retailers.

The haphazard state-level legalization of cannabis in the US has created a patchwork of vastly different regulations across states, from growing to retail licensing. How do we make sense of the opportunities that exist?

While traditionally excluded by ESG investors, tobacco companies have made great strides over the last few years with the introduction of a wide range of reduced risk products (RRPs).

In this episode we spoke with Linda Lebrun from Substack Inc., a VC-backed publishing platform that has gained prominence in recent years as the go-to place for starting and monetizing email newsletters.

Expert interview transcript libraries are the easiest way to access primary research, which fuels better decisions for both investors and corporate professionals. But how are compliance issues resolved both on the library side, and on the client side?

In this episode, we spoke with Michael Maloof from Earnest Analytics, a leading provider of alternative data.